Conduit enters joint development with Manoira for AZD1656/AZD5658 in animal health

CDT Equity Inc.

Conduit grants Manoira non-exclusive license to AZD1656 and AZD5658 for veterinary use; Manoira funds development.
Conduit issued 154,799 shares at $3.23/share (~$500K) to Manoira, a company controlled by CEO Andrew Regan.
Initial evaluation focuses on AZD1656 in canine osteoarthritis; plans combination with patented CBDA co-crystal.
Conduit retains all human IP and data ownership; agreement provides cross-species translational data for human programs.
Collaboration targets potential revenue in $15B animal health market (6.5% CAGR through 2027).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.